Sex reversal following deletion of a single distal enhancer of <i>Sox9</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29903884.
- Also identified by DOI 10.1126/science.aas9408 and PMC identifier 6034650.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cell fate decisions require appropriate regulation of key genes. <i>Sox9</i>, a direct target of SRY, is pivotal in mammalian sex determination. In vivo high-throughput chromatin accessibility techniques, transgenic assays, and genome editing revealed several novel gonadal regulatory elements in the 2-megabase gene desert upstream of <i>Sox9</i> Although others are redundant, enhancer 13 (Enh13), a 557-base pair element located 565 kilobases 5' from the transcriptional start site, is essential to initiate mouse testis development; its deletion results in XY females with <i>Sox9</i> transcript levels equivalent to those in XX gonads. Our data are consistent with the time-sensitive activity of SRY and indicate a strict order of enhancer usage. Enh13 is conserved and embedded within a 32.5-kilobase region whose deletion in humans is associated with XY sex reversal, suggesting that it is also critical in humans.
Medical subject headings
- Enhancer Elements, Genetic
- Gonadal Dysgenesis, 46,XY
- SOX9 Transcription Factor
- Sex Determination Processes
- Sex-Determining Region Y Protein
- Testis